Michael Bettess
Presidente en Currus Biologics Pty Ltd. .
Perfil
Michael Bettess is currently the Chairman at Currus Biologics Pty Ltd., the Director at Cincera Therapeutics Pty Ltd., and the Senior Investment Manager at Brandon Capital Partners Pty Ltd.
He previously worked as the Director at Heart Metabolics Ltd.
and as the Investment Manager at Trans Tasman Fund Management Pty Ltd.
Dr. Bettess obtained an MBA from LaTrobe University in 2008.
Cargos activos de Michael Bettess
Empresas | Cargo | Inicio |
---|---|---|
Brandon Capital Partners Pty Ltd.
Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners Pty Ltd. (Brandon Capital Partners) is a venture capital firm founded in 2007 by David Fisher and Chris Nave. The firm is headquartered in Sydney, Australia. | Inversor de Capital Privado | 01/02/2016 |
Cincera Therapeutics Pty Ltd.
Cincera Therapeutics Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Cincera Therapeutics Pty Ltd. is a biotechnology company, which develops molecule drugs. It focuses on the discovery and development of new small molecule drugs aiming to treat difficult-to-treat inflammatory and fibrotic conditions associated with obesity and metabolic disorders, with potential applications in many other disease areas including cancer. The company was founded by Bernard Flynn and Stuart Pitson and is headquartered in Melbourne, Australia. | Director/Miembro de la Junta | - |
Currus Biologics Pty Ltd.
Currus Biologics Pty Ltd. BiotechnologyHealth Technology Currus Biologics Pty Ltd. is an Australian biotechnology company that develops cell therapies to treat cancers. The company is based in Melbourne, Australia. The CEO of the company is Samantha Cobb. | Presidente | - |
Antiguos cargos conocidos de Michael Bettess.
Empresas | Cargo | Fin |
---|---|---|
Trans Tasman Fund Management Pty Ltd.
Trans Tasman Fund Management Pty Ltd. Investment ManagersFinance Trans Tasman Fund Management Pty Ltd (TTCF) is a venture capital firm headquartered in Australia. | Inversor de Capital Privado | - |
Heart Metabolics Ltd.
Heart Metabolics Ltd. BiotechnologyHealth Technology Heart Metabolics Ltd. operates as a biopharmaceutical company that engages in developing new treatments for orphan disease including cardio-metabolic diseases. The firm provides drugs to treat heart failure for hypertrophic cardiomyopathy patients. The company was founded by Michael Paul Frenneaux and Houshman Ashrafian in 2004 and is headquartered in Dublin, Ireland. | Director/Miembro de la Junta | - |
Formación de Michael Bettess.
LaTrobe University | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 5 |
---|---|
Brandon Capital Partners Pty Ltd.
Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners Pty Ltd. (Brandon Capital Partners) is a venture capital firm founded in 2007 by David Fisher and Chris Nave. The firm is headquartered in Sydney, Australia. | Finance |
Trans Tasman Fund Management Pty Ltd.
Trans Tasman Fund Management Pty Ltd. Investment ManagersFinance Trans Tasman Fund Management Pty Ltd (TTCF) is a venture capital firm headquartered in Australia. | Finance |
Heart Metabolics Ltd.
Heart Metabolics Ltd. BiotechnologyHealth Technology Heart Metabolics Ltd. operates as a biopharmaceutical company that engages in developing new treatments for orphan disease including cardio-metabolic diseases. The firm provides drugs to treat heart failure for hypertrophic cardiomyopathy patients. The company was founded by Michael Paul Frenneaux and Houshman Ashrafian in 2004 and is headquartered in Dublin, Ireland. | Health Technology |
Cincera Therapeutics Pty Ltd.
Cincera Therapeutics Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Cincera Therapeutics Pty Ltd. is a biotechnology company, which develops molecule drugs. It focuses on the discovery and development of new small molecule drugs aiming to treat difficult-to-treat inflammatory and fibrotic conditions associated with obesity and metabolic disorders, with potential applications in many other disease areas including cancer. The company was founded by Bernard Flynn and Stuart Pitson and is headquartered in Melbourne, Australia. | Commercial Services |
Currus Biologics Pty Ltd.
Currus Biologics Pty Ltd. BiotechnologyHealth Technology Currus Biologics Pty Ltd. is an Australian biotechnology company that develops cell therapies to treat cancers. The company is based in Melbourne, Australia. The CEO of the company is Samantha Cobb. | Health Technology |
- Bolsa de valores
- Insiders
- Michael Bettess